NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute and its partners Nemucore Medical Innovations and Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have received a $3 million grant to fund a personalized glioblastoma treatment study.

TGen said yesterday that the funding from the Ben & Catherine Ivy Foundation will support a trial using individual tumor genetics to optimize targeted glioblastoma therapies that will be delivered via nanotechnology tools.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.